SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-007472
Filing Date
2023-03-13
Accepted
2023-03-13 17:25:17
Documents
116
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2023539
2 ex4-1.htm EX-4.1 46163
3 ex21-1.htm EX-21.1 2451
4 ex23-1.htm EX-23.1 3935
5 ex31-1.htm EX-31.1 11552
6 ex31-2.htm EX-31.2 11167
7 ex32-1.htm EX-32.1 8225
8 ex32-2.htm EX-32.2 8515
  Complete submission text file 0001493152-23-007472.txt   8774108

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20221231.xsd EX-101.SCH 72697
10 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bfri-20221231_cal.xml EX-101.CAL 94600
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20221231_def.xml EX-101.DEF 298785
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20221231_lab.xml EX-101.LAB 559263
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20221231_pre.xml EX-101.PRE 450829
110 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1124667
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40943 | Film No.: 23728289
SIC: 2834 Pharmaceutical Preparations